Cargando…
Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests
BACKGROUND: With the rapid demographic change in Korea, Alzheimer’s disease has become a primary concern. Recent developments in disease-modifying therapies provide hope that therapy may become available soon. The high disease prevalence and complex evaluation process will create challenges for the...
Autores principales: | Jun, Hankyung, Cho, Sang Kyu, Yoong, Joanne, Mattke, Soeren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Geriatrics Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024173/ https://www.ncbi.nlm.nih.gov/pubmed/33550774 http://dx.doi.org/10.4235/agmr.20.0082 |
Ejemplares similares
-
Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment
por: Lam, Jenny, et al.
Publicado: (2021) -
Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States
por: Prados, Maria J., et al.
Publicado: (2022) -
Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times
por: Mattke, Soeren, et al.
Publicado: (2020) -
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis
por: Mattke, Soeren, et al.
Publicado: (2023) -
Outpatient Wound Clinics During COVID-19 Maintained Quality but Served Fewer Patients
por: Cho, Sang Kyu, et al.
Publicado: (2022)